ARROWSTREET CAPITAL, LIMITED PARTNERSHIP

Position in ANAB — Anaptysbio, Inc

CIK 1164508 BOSTON, MA

Position in ANAB

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$32,983,942

+$5,690,992 QoQ

Shares Held

488,651

-33.8% QoQ

Ownership

1.68%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#19

of 211 holders

Holding Since

Jun 2020

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $2,519,535,758 across 72 Biotechnology names. ANAB ranks #20 (1.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	738,378	$366,774,503
2	INCY	Incyte Corp	2,744,958	$311,168,438
3	REGN	Regeneron Pharmaceuticals, Inc.	393,685	$245,478,344
4	EXEL	Exelixis, Inc.	4,365,926	$237,550,033
5	GMAB	Genmab A/S	4,975,324	$136,672,150
6	RPRX	Royalty Pharma plc	2,435,341	$136,549,569
7	HALO	Halozyme Therapeutics, Inc.	1,704,623	$133,420,842
8	ONC	BeOne Medicines Ltd.	249,758	$71,173,537

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$32,983,942	488,651	-0.7%	Shares	Defined	2026-08-13
2026-03-31	$27,292,950	492,120	-12.1%	Shares	Defined	2026-05-14
2025-12-31	$27,136,389	559,744	+51.1%	Shares	Defined	2026-02-13
2025-09-30	$11,343,405	370,458	+145.6%	Shares	Defined	2025-11-13
2025-06-30	$3,347,982	150,810	+1429.2%	Shares	Defined	2025-08-13
2022-03-31	$243,985	9,862	-86.4%	Shares	Defined	2022-05-13
2021-12-31	$2,519,413	72,501	-49.4%	Shares	Defined	2022-02-14
2020-12-31	$3,083,415	143,415	-8.3%	Shares	Defined	2021-02-12
2020-09-30	$2,305,638	156,315	+68.5%	Shares	Defined	2020-11-12
2020-06-30	$2,072,767	92,783	—	Shares	Defined	2020-08-12
No filing history on record for this holder in this stock.